 |
| November
3, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Lewis H. Bender, Founder & CEO,
Intensity Therapeutics |
| In
this Q&A, Bender discusses the
insight behind Intensity's
approach, what sets its delivery
platform apart, lessons he's
learned leading a biotech company
through an IPO and late-stage
trials, and changes needed to get
more effective, less toxic
treatments to patients faster.
More |
|
|
|
 |
|
One Partner For Your Entire
Vivarium. Research Ready From Day
One. |
|
Learn More
→ |
|
|
- Aarvik Therapeutics: Milestone
Achievement, Partnership Update, and
Presentations on MUTTA and AQUALINK
Platforms at the 17th Annual WADC Conference
More
- CareDx: Third KOAR Analysis Published in
Transplantation More
- Ceribell: Expands Its Point-of-Care Brain
Monitoring Platform With Commercial Launch of
Delirium Monitoring Solution More
- Cerus: Positive Topline Results From
Phase 3 RedeS Trial of the INTERCEPT Blood
System for Red Blood Cells More
- Eureka Therapeutics: Appoints Surgical
Oncologist Dr. Jennifer F. Tseng to Scientific
Advisory Board More
- HeartBeam: Positive Heart Attack Pilot Study
Results at TCT 2026 - Patient-Recorded 3D ECG
Shown to Be as Accurate as Standard 12-Lead
ECG More
- Inquis Medical: Launches a Large Multicenter
Post-Market Registry to Build on Positive
AVENTUS Pivotal Trial Results With Real-World
Evidence in Pulmonary Embolism More
- Jupiter Endovascular: New SPIRARE II Data at
TCT 2026 Show Restoring Normal Pulmonary
Pressure Using Vertex System Tracked With
Right Heart Recovery in Pulmonary Embolism More
- Mirum Pharmaceuticals: Showcases Momentum
Across Rare Liver Disease Portfolio With New
Data at AASLD’s The Liver Meeting 2026 More
- Ultima
Genomics: Major Sequencing Award for
Singapore's National Precision Medicine (NPM)
Program Phase III More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- BioMarin: Third Quarter 2026 Financial and
Operating Results More
- Biopharma Therapeutics and Platforms R&D
Partnerships – Q3 2026 Review More
- Cerus: Third Quarter 2026 Financial Results
More
- SI-BONE: Financial Results for the Third
Quarter 2026 and Reaffirms 2026 Revenue
Guidance More
|
|
 |
| Surplus
lab equipment? Excess Logic
decommissions it nationwide and
pays you back up to 80% of its
resale value. |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Lewis H.
Bender, Founder & CEO, Intensity
Therapeutics More
- Biotech & Pharma Updates | November 2,
2026 More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- CollectiveMinds: The Boardroom Is
Changing. Is Your Experience Visible?
More
- Intuitive: Appoints Aaron Martin to Its
Board of Directors
More
- Layoff Tracker: Vistagen Cuts Workforce for
Second Time in 2026 More
- OPPORTUNITY: Director of Compliance, Remote
More
- OPPORTUNITY: Head of Market
Development & Strategy, California More
- OPPORTUNITY: Senior Vice President,
Regulatory Affairs & Quality Assurance,
Boston More
- Slone Partners: Doing More With Less
- Building the Right Nonprofit Leadership
Team in a Resource-Constrained Environment More
- Slone Partners: Leading Through AI - The New
Playbook for Healthtech Executives More
- U.S. Bioscience Jobs Up 7% From 2021 to
2025: Report More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Aggression in Mice: Bridging Evidence,
Best Practices, and Scientific Rigor Nov
4
- BioScience Forum: Targeting RAS-Addicted
Cancers with RAS (ON) Tri-Complex Inhibitors Nov
5
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
- Pricing & Contracting WEST (Use
code 26B4B10 for 10% off) Dec
7-8
- Trade and Channel Strategies (Use
code 26B4B10 for 10% off) Dec
8-10
- Advancing Drug Development Forum Dec
10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
